Skip to content

Spectroscopic Analysis of Tongue Tumor Samples.

Prospective Analysis of Tumor Tissues From the Oral Cavity by SpiderMassTM Spectroscopy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05104619
Acronym
SpecTum
Enrollment
33
Registered
2021-11-03
Start date
2021-03-10
Completion date
2026-10-01
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mass Spectroscopy, Molecular Profile, Oral Cavity, Squamous Cell Carcinoma, Surgical Margins, Tongue

Keywords

mass spectroscopy, molecular profile, surgical margins, squamous cell carcinoma, oral cavity, tongue

Brief summary

In squamous cell carcinoma of the tongue, complete surgical resection of the tumor generally represents the primary treatment strategy. Among factors determining the disease prognostic, the surgical margins status is essential for the continued management of the patient, with or without complementary therapies. Generally, surgical margins are defined using visual and tactile elements. Unfortunately, in 15 to 30 percent of cases, they are defined as positive after histopathological examination, on average 5 to 7 days post-surgery. Techniques have recently been developed to analyze the cancerous and non-cancerous nature of tissues, using the spectral properties of tumor cells. SpiderMass™ is an instrument equipped with a probe for tissue micro-sampling and real-time molecular profile analysis. It is thus ultimately a tool for anatomopathological decision support, for diagnosis and prognosis of the disease. Used in the operating room, SpiderMass™ could also become an innovative surgical tool to precisely define cancerous areas in situ and the margins status in intraoperative conditions. Based on the principle of artificial intelligence, the SpiderMass™ machine must initially learn to recognize pathological tissues versus healthy. This project aims to accomplish this first phase of machine learning for squamous cell carcinoma of the tongue.

Interventions

PROCEDUREtongue surgery

In squamous cell carcinoma of the tongue, complete surgical resection of the tumor

Sponsors

Centre Hospitalier Universitaire, Amiens
Lead SponsorOTHER
Université de Lille
CollaboratorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age : 18 years and older * squamous cell carcinoma of the tongue * surgical resection as first-line treatment * tumor classification T1 to T4.

Exclusion criteria

* metastatic disease * neoadjuvant therapies

Design outcomes

Primary

MeasureTime frameDescription
Tumor cells detection in tongue tumor with SpiderMass technique1 yearTumor cells detection in tongue tumor with SpiderMass technique

Countries

France

Contacts

CONTACTChristophe ATTENCOURT, MD
attencourt.christophe@chu-amiens.fr03 22 66 87 66

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 16, 2026